Skip to main content
Top
Published in: BMC Pregnancy and Childbirth 1/2024

Open Access 01-12-2024 | Metastasis | Case Report

Intracardiac metastasis of gestational choriocarcinoma: a case report and literature review

Authors: Yu Gu, Haoran Zheng, Xiaowei Xue, Dan Wang, Hongyan Cheng, Liju Zong, Yang Xiang

Published in: BMC Pregnancy and Childbirth | Issue 1/2024

Login to get access

Abstract

Introduction

Gestational trophoblastic neoplasia (GTN) with intracardiac metastasis is rare, and here we reported a patient with intracardiac metastasis of high-risk and refractory gestational choriocarcinoma and reviewed relevant literatures.

Case presentation

A 37-year-old woman presented with vaginal bleeding and high level of β-human chorionic gonadotropin (β-hCG) at 199,060 (mIU/mL). It was clinically diagnosed with gestational choriocarcinoma. The patient initially received eight cycles of chemotherapy but unsatisfactory response was observed, and the level of β-hCG still ranged between 5000 and 10,000. Then there was found intracardiac masses in the right atrium (2.6*1.7 cm), anterior chordae tendineae of the tricuspid valve (1.4*0.7 cm) and the right ventricle (4.1*2.9 cm) by ultrasonic cardiogram (UCG). PET/CT highly suspected the intracardiac metastasis of choriocarcinoma (SUVmax = 9.3) and no disease was found in the lung and pelvis. The patient undertook complete intracardiac masses resection. The pathology confirmed the intracardiac metastasis of disease. After a week of operation, the UCG found a 5.4*4.2 cm mass in the right atrium again. Considering the poor prognosis, the patient received palliative care and eventually died of disease progression.

Conclusion

Intracardiac metastasis of GTN is an aggressive sign of disease. Patients can benefit from chemotherapy and surgery. Future investigation of PD-1 immunotherapy combines with chemotherapy are expected to improve the prognosis in this group of patients.
Literature
1.
go back to reference Seckl MJ, Sebire NJ, Berkowitz RS. Gestational trophoblastic Disease. Lancet. 2010;376(9742):717–29.CrossRefPubMed Seckl MJ, Sebire NJ, Berkowitz RS. Gestational trophoblastic Disease. Lancet. 2010;376(9742):717–29.CrossRefPubMed
2.
go back to reference Silva A, Monteiro KDN, Sun SY, Borbely AU. Gestational trophoblastic neoplasia: novelties and challenges. Placenta. 2021;116:38–42.CrossRefPubMed Silva A, Monteiro KDN, Sun SY, Borbely AU. Gestational trophoblastic neoplasia: novelties and challenges. Placenta. 2021;116:38–42.CrossRefPubMed
3.
go back to reference Hoffner L, Surti U. The genetics of gestational trophoblastic disease: a rare complication of pregnancy. Cancer Genet. 2012;205(3):63–77.CrossRefPubMed Hoffner L, Surti U. The genetics of gestational trophoblastic disease: a rare complication of pregnancy. Cancer Genet. 2012;205(3):63–77.CrossRefPubMed
4.
go back to reference Lurain JR. Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol. 2010;203(6):531–9.CrossRefPubMed Lurain JR. Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol. 2010;203(6):531–9.CrossRefPubMed
5.
go back to reference Seckl MJ, Sebire NJ, Fisher RA, Golfier F, Massuger L, Sessa C. Gestational trophoblastic disease: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi39-50.CrossRefPubMed Seckl MJ, Sebire NJ, Fisher RA, Golfier F, Massuger L, Sessa C. Gestational trophoblastic disease: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi39-50.CrossRefPubMed
6.
go back to reference Dudiak KM, Maturen KE, Akin EA, Bell M, Bhosale PR, Kang SK, Kilcoyne A, Lakhman Y, Nicola R, Pandharipande PV, et al. ACR appropriateness criteria® gestational trophoblastic disease. J Am Coll Radiol. 2019;16(11s):348-s363.CrossRef Dudiak KM, Maturen KE, Akin EA, Bell M, Bhosale PR, Kang SK, Kilcoyne A, Lakhman Y, Nicola R, Pandharipande PV, et al. ACR appropriateness criteria® gestational trophoblastic disease. J Am Coll Radiol. 2019;16(11s):348-s363.CrossRef
7.
go back to reference Ngan HYS, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, Lurain JR, Massuger L. Diagnosis and management of gestational trophoblastic disease: 2021 update. Int J Gynaecol Obstet. 2021;155(Suppl 1):86–93.CrossRefPubMedPubMedCentral Ngan HYS, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, Lurain JR, Massuger L. Diagnosis and management of gestational trophoblastic disease: 2021 update. Int J Gynaecol Obstet. 2021;155(Suppl 1):86–93.CrossRefPubMedPubMedCentral
8.
go back to reference Chu Y, Xu F, Ren Z, Hu X, Wang L, Yue J. Splenic Metastatic Choriocarcinoma with Nontraumatic Splenic Rupture: A Case Report and Literature Review. J Clin Med. 2022;12(1):157. Chu Y, Xu F, Ren Z, Hu X, Wang L, Yue J. Splenic Metastatic Choriocarcinoma with Nontraumatic Splenic Rupture: A Case Report and Literature Review. J Clin Med. 2022;12(1):157.
9.
go back to reference Borella F, Cosma S, Ferraioli D, Preti M, Gallio N, Valabrega G, Scotto G, Rolfo A, Castellano I, Cassoni P, et al. From uterus to brain: an update on epidemiology, clinical features, and treatment of brain metastases from gestational trophoblastic neoplasia. Front Oncol. 2022;12: 859071.CrossRefPubMedPubMedCentral Borella F, Cosma S, Ferraioli D, Preti M, Gallio N, Valabrega G, Scotto G, Rolfo A, Castellano I, Cassoni P, et al. From uterus to brain: an update on epidemiology, clinical features, and treatment of brain metastases from gestational trophoblastic neoplasia. Front Oncol. 2022;12: 859071.CrossRefPubMedPubMedCentral
10.
go back to reference Cheng H, Yang J, Ren T, Zhao J, Feng F, Wan X, Xiang Y. Gestational trophoblastic neoplasia with urinary system metastasis: a single center experience. Front Oncol. 2020;10: 1208.CrossRefPubMedPubMedCentral Cheng H, Yang J, Ren T, Zhao J, Feng F, Wan X, Xiang Y. Gestational trophoblastic neoplasia with urinary system metastasis: a single center experience. Front Oncol. 2020;10: 1208.CrossRefPubMedPubMedCentral
11.
go back to reference Ober WB, Edgcomb JH, Price EB Jr. The pathology of choriocarcinoma. Ann N Y Acad Sci. 1971;172(10):299–426.CrossRefPubMed Ober WB, Edgcomb JH, Price EB Jr. The pathology of choriocarcinoma. Ann N Y Acad Sci. 1971;172(10):299–426.CrossRefPubMed
12.
go back to reference Akaike A, Ito T, Sada T, Kamyar R, Koro T, Matsumoto S, Ito Y, Mohri N, Kobayashi T. Myocardial Infarction due to metastasis of choriocarcinoma in a 29-year-old woman. Jpn Circ J. 1977;41(11):1257–63.CrossRefPubMed Akaike A, Ito T, Sada T, Kamyar R, Koro T, Matsumoto S, Ito Y, Mohri N, Kobayashi T. Myocardial Infarction due to metastasis of choriocarcinoma in a 29-year-old woman. Jpn Circ J. 1977;41(11):1257–63.CrossRefPubMed
13.
go back to reference Seigle JM, Caputy AJ, Manz HJ, Wheeler C, Fox JL. Multiple oncotic intracranial aneurysms and cardiac metastasis from choriocarcinoma: case report and review of the literature. Neurosurgery. 1987;20(1):39–42.CrossRefPubMed Seigle JM, Caputy AJ, Manz HJ, Wheeler C, Fox JL. Multiple oncotic intracranial aneurysms and cardiac metastasis from choriocarcinoma: case report and review of the literature. Neurosurgery. 1987;20(1):39–42.CrossRefPubMed
14.
go back to reference Vasiljevic JD, Abdulla AK. Coronary embolism by metastatic choriocarcinoma of the uterus: an unusual cause of ischemic heart disease. Gynecol Oncol. 1990;38(2):289–92.CrossRefPubMed Vasiljevic JD, Abdulla AK. Coronary embolism by metastatic choriocarcinoma of the uterus: an unusual cause of ischemic heart disease. Gynecol Oncol. 1990;38(2):289–92.CrossRefPubMed
15.
go back to reference Kishore AG, Desai N, Nayak G. Choriocarcinoma presenting as intracavitary tumor in the left atrium. Int J Cardiol. 1992;35(3):405–7.CrossRefPubMed Kishore AG, Desai N, Nayak G. Choriocarcinoma presenting as intracavitary tumor in the left atrium. Int J Cardiol. 1992;35(3):405–7.CrossRefPubMed
16.
go back to reference Perroni D, Grecchi GL, La Ciura P, Landoni F. Right ventricular metastasis from choriocarcinoma: report of a rare case and review of the literature. Eur J Surg Oncol. 1993;19(4):378–81.PubMed Perroni D, Grecchi GL, La Ciura P, Landoni F. Right ventricular metastasis from choriocarcinoma: report of a rare case and review of the literature. Eur J Surg Oncol. 1993;19(4):378–81.PubMed
17.
go back to reference Bohlmann MK, Eckstein FS, Allemann Y, Stauffer E, Carrel TP. Intracardiac resection of a metastatic choriocarcinoma. Gynecol Oncol. 2002;84(1):157–60.CrossRefPubMed Bohlmann MK, Eckstein FS, Allemann Y, Stauffer E, Carrel TP. Intracardiac resection of a metastatic choriocarcinoma. Gynecol Oncol. 2002;84(1):157–60.CrossRefPubMed
18.
go back to reference Bozaci EA, Taşkin S, Gürkan O, Atasoy C, Ersoy ZG, Erekul S, Numanoğlu N, Ortaç F. Intracavitary cardiac metastasis and pulmonary tumor emboli of choriocarcinoma: the first case diagnosed and treated without surgical intervention. Gynecol Oncol. 2005;99(3):753–6.CrossRefPubMed Bozaci EA, Taşkin S, Gürkan O, Atasoy C, Ersoy ZG, Erekul S, Numanoğlu N, Ortaç F. Intracavitary cardiac metastasis and pulmonary tumor emboli of choriocarcinoma: the first case diagnosed and treated without surgical intervention. Gynecol Oncol. 2005;99(3):753–6.CrossRefPubMed
19.
go back to reference Vincent M, Court-Fortune I, Karpathiou G, Froudarakis ME, Vergnon JM. An extremely rare case of postpartum gestational choriocarcinoma with long-term survival. Tumori. 2017;103(Suppl 1):e16-18.CrossRefPubMed Vincent M, Court-Fortune I, Karpathiou G, Froudarakis ME, Vergnon JM. An extremely rare case of postpartum gestational choriocarcinoma with long-term survival. Tumori. 2017;103(Suppl 1):e16-18.CrossRefPubMed
20.
go back to reference Li Y, Yan L, Shui S, Han X. Choriocarcinoma metastasis in the left atrium. Eur Heart J. 2020;41(28):2628.CrossRefPubMed Li Y, Yan L, Shui S, Han X. Choriocarcinoma metastasis in the left atrium. Eur Heart J. 2020;41(28):2628.CrossRefPubMed
22.
go back to reference Kopcik K, Kościelecka K, Krzyżak K. Cardiac Metastatic Tumors: Current Knowledge. Am J Clin Oncol. 2023;46(8):374–9. Kopcik K, Kościelecka K, Krzyżak K. Cardiac Metastatic Tumors: Current Knowledge. Am J Clin Oncol. 2023;46(8):374–9.
23.
go back to reference Rahouma M, Arisha MJ, Elmously A, El-Sayed Ahmed MM, Spadaccio C, Mehta K, Baudo M, Kamel M, Mansor E, Ruan Y, et al. Cardiac tumors prevalence and mortality: a systematic review and meta-analysis. Int J Surg. 2020;76:178–89.CrossRefPubMed Rahouma M, Arisha MJ, Elmously A, El-Sayed Ahmed MM, Spadaccio C, Mehta K, Baudo M, Kamel M, Mansor E, Ruan Y, et al. Cardiac tumors prevalence and mortality: a systematic review and meta-analysis. Int J Surg. 2020;76:178–89.CrossRefPubMed
24.
go back to reference Poterucha TJ, Kochav J, O’Connor DS, Rosner GF. Cardiac tumors: clinical presentation, diagnosis, and management. Curr Treat Options Oncol. 2019;20(8):66.CrossRefPubMed Poterucha TJ, Kochav J, O’Connor DS, Rosner GF. Cardiac tumors: clinical presentation, diagnosis, and management. Curr Treat Options Oncol. 2019;20(8):66.CrossRefPubMed
25.
go back to reference Burazor I, Aviel-Ronen S, Imazio M, Goitein O, Perelman M, Shelestovich N, Radovanovic N, Kanjuh V, Barshack I, Adler Y. Metastatic cardiac tumors: from clinical presentation through diagnosis to treatment. BMC Cancer. 2018;18(1):202.CrossRefPubMedPubMedCentral Burazor I, Aviel-Ronen S, Imazio M, Goitein O, Perelman M, Shelestovich N, Radovanovic N, Kanjuh V, Barshack I, Adler Y. Metastatic cardiac tumors: from clinical presentation through diagnosis to treatment. BMC Cancer. 2018;18(1):202.CrossRefPubMedPubMedCentral
26.
go back to reference Deleuze A, Massard C, Le Du F, You B, Lefeuvre-Plesse C, Bolze PA, de la Motte Rouge T. Management of trophoblastic tumors : review of evidence, current practice, and future directions. Expert Rev Anticancer Ther. 2023;23(7):699–708. Deleuze A, Massard C, Le Du F, You B, Lefeuvre-Plesse C, Bolze PA, de la Motte Rouge T. Management of trophoblastic tumors : review of evidence, current practice, and future directions. Expert Rev Anticancer Ther. 2023;23(7):699–708.
27.
go back to reference Wang X, Cang W, Liu X, Cheng Y, Wan X, Feng F, Ren T, Zhao J, Jiang F, Cheng H, et al. Anti-PD-1 therapy plus chemotherapy versus anti-PD-1 therapy alone in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia: a multicenter, retrospective study. EClinicalMedicine. 2023;59: 101974.CrossRefPubMedPubMedCentral Wang X, Cang W, Liu X, Cheng Y, Wan X, Feng F, Ren T, Zhao J, Jiang F, Cheng H, et al. Anti-PD-1 therapy plus chemotherapy versus anti-PD-1 therapy alone in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia: a multicenter, retrospective study. EClinicalMedicine. 2023;59: 101974.CrossRefPubMedPubMedCentral
28.
go back to reference Cheng H, Zong L, Kong Y, Wang X, Gu Y, Cang W, Zhao J, Wan X, Yang J, Xiang Y. Camrelizumab plus Apatinib in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia (CAP 01): a single-arm, open-label, phase 2 trial. Lancet Oncol. 2021;22(11):1609–17.CrossRefPubMed Cheng H, Zong L, Kong Y, Wang X, Gu Y, Cang W, Zhao J, Wan X, Yang J, Xiang Y. Camrelizumab plus Apatinib in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia (CAP 01): a single-arm, open-label, phase 2 trial. Lancet Oncol. 2021;22(11):1609–17.CrossRefPubMed
29.
go back to reference Albright BB, Ellett T, Knochenhauer HE, Goins EC, Monuszko KA, Kaplan SJ, Previs RA, Moss HA, Havrilesky LJ, Davidson BA. Treatments and outcomes in high-risk gestational trophoblastic neoplasia: a systematic review and meta-analysis. BJOG. 2023;130(5):443–53.CrossRefPubMed Albright BB, Ellett T, Knochenhauer HE, Goins EC, Monuszko KA, Kaplan SJ, Previs RA, Moss HA, Havrilesky LJ, Davidson BA. Treatments and outcomes in high-risk gestational trophoblastic neoplasia: a systematic review and meta-analysis. BJOG. 2023;130(5):443–53.CrossRefPubMed
30.
go back to reference Veras E, Kurman RJ, Wang TL, Shih IM. PD-L1 expression in human placentas and gestational trophoblastic diseases. Int J Gynecol Pathol. 2017;36(2):146–53.CrossRefPubMedPubMedCentral Veras E, Kurman RJ, Wang TL, Shih IM. PD-L1 expression in human placentas and gestational trophoblastic diseases. Int J Gynecol Pathol. 2017;36(2):146–53.CrossRefPubMedPubMedCentral
31.
go back to reference Inaguma S, Wang Z, Lasota J, Sarlomo-Rikala M, McCue PA, Ikeda H, Miettinen M. Comprehensive immunohistochemical study of programmed cell death Ligand 1 (PD-L1): analysis in 5536 cases revealed consistent expression in trophoblastic tumors. Am J Surg Pathol. 2016;40(8):1133–42.CrossRefPubMedPubMedCentral Inaguma S, Wang Z, Lasota J, Sarlomo-Rikala M, McCue PA, Ikeda H, Miettinen M. Comprehensive immunohistochemical study of programmed cell death Ligand 1 (PD-L1): analysis in 5536 cases revealed consistent expression in trophoblastic tumors. Am J Surg Pathol. 2016;40(8):1133–42.CrossRefPubMedPubMedCentral
32.
go back to reference Cheng H, Zong L, Yu S, Chen J, Wan X, Xiang Y, Yang J. Expression of the immune targets in tumor-infiltrating immunocytes of gestational trophoblastic neoplasia. Pathol Oncol Research. 2023;29:1610918.CrossRef Cheng H, Zong L, Yu S, Chen J, Wan X, Xiang Y, Yang J. Expression of the immune targets in tumor-infiltrating immunocytes of gestational trophoblastic neoplasia. Pathol Oncol Research. 2023;29:1610918.CrossRef
Metadata
Title
Intracardiac metastasis of gestational choriocarcinoma: a case report and literature review
Authors
Yu Gu
Haoran Zheng
Xiaowei Xue
Dan Wang
Hongyan Cheng
Liju Zong
Yang Xiang
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Pregnancy and Childbirth / Issue 1/2024
Electronic ISSN: 1471-2393
DOI
https://doi.org/10.1186/s12884-023-06144-w

Other articles of this Issue 1/2024

BMC Pregnancy and Childbirth 1/2024 Go to the issue